Joslin Diabetes Center-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Joslin Diabetes Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014092
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Joslin Diabetes Center (Joslin) is a healthcare service provider that provides diabetes treatment, research and education services. The centers services include weight management programs, pregnancy program, eye care, diabetes prevention, research, diabetes patient education, adult diabetic care, and clinical research studies. It also offer cardiovascular program, exercise, foot care, kidney health, latino clinic, lipids clinic, mental health and counseling services. Joslin provides geriatrics, insulin pump program, peripheral neuropathy clinic, pregnancy program, nutrition programs, pediatrics, and sexual function clinic. The center also provides inpatient medical consultations. It offers basic research, clinical research and patient care for both adults and children. Joslin is headquartered in Boston, Massachusetts, the US.

Joslin Diabetes Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Joslin Diabetes Center, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Joslin Diabetes Center, Medical Devices Deals, 2011 to YTD 2017 9
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sanofi Enters into Co-Development Agreement with Joslin Diabetes Center 11
GI Windows to Enter into Research Agreement with Joslin Diabetes Center 12
Diasome Pharma Enters into Agreement with Joslin Diabetes Center 13
MedImmune Enters into Research Agreement with Joslin Diabetes Center 14
Joslin Diabetes Center Enters Into R&D Agreement With Johnson & Johnson For Diabetes Management 15
Joslin Diabetes Center Enters Into Co-Development Agreement With Pfizer And Lilly 16
Massachusetts Eye & Ear And Joslin Diabetes Center Partner For Eye Care 17
Sanofi Enters Into Co-Development Agreement With Joslin Diabetes Center For Novel Diabetes Drugs 18
Licensing Agreements 19
Ember Therapeutics Enters Into Licensing Agreement With Joslin Diabetes Center For Brown Fat Technology and Intellectual Property 19
Joslin Diabetes Center – Key Competitors 20
Joslin Diabetes Center – Key Employees 21
Joslin Diabetes Center – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Key Facts 2
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Joslin Diabetes Center, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Joslin Diabetes Center, Deals By Therapy Area, 2011 to YTD 2017 8
Joslin Diabetes Center, Medical Devices Deals, 2011 to YTD 2017 9
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sanofi Enters into Co-Development Agreement with Joslin Diabetes Center 11
GI Windows to Enter into Research Agreement with Joslin Diabetes Center 12
Diasome Pharma Enters into Agreement with Joslin Diabetes Center 13
MedImmune Enters into Research Agreement with Joslin Diabetes Center 14
Joslin Diabetes Center Enters Into R&D Agreement With Johnson & Johnson For Diabetes Management 15
Joslin Diabetes Center Enters Into Co-Development Agreement With Pfizer And Lilly 16
Massachusetts Eye & Ear And Joslin Diabetes Center Partner For Eye Care 17
Sanofi Enters Into Co-Development Agreement With Joslin Diabetes Center For Novel Diabetes Drugs 18
Ember Therapeutics Enters Into Licensing Agreement With Joslin Diabetes Center For Brown Fat Technology and Intellectual Property 19
Joslin Diabetes Center, Key Competitors 20
Joslin Diabetes Center, Key Employees 21
Joslin Diabetes Center, Other Locations 22

★海外企業調査レポート[Joslin Diabetes Center-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The E. W. Scripps Company:企業の戦略・SWOT・財務分析
    The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report Summary The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Spire Inc (SR):企業の財務・戦略的SWOT分析
    Spire Inc (SR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Magnolia Petroleum Plc (MAGP):企業の財務・戦略的SWOT分析
    Summary Magnolia Petroleum Plc (Magnolia Petroleum) is an oil and gas company. The company explores, acquires, and develops oil and natural gas properties. It holds interests in producing properties in two project areas such as Bakken shale in North Dakota and the proven Mississippi Lime, Woodford a …
  • Jura Energy Corp (JEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Jura Energy Corp (Jura Energy), formerly Proprietary Industries Inc., is an independent upstream company. It explores, develops and produces crude oil and natural gas from its assets in Pakistan. The company undertakes upstream operations in Pakistan through its wholly-owned subsidiaries, na …
  • American Axle & Manufacturing Holdings Inc (AXL):企業の財務・戦略的SWOT分析
    American Axle & Manufacturing Holdings Inc (AXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Trustpower Ltd:企業の戦略的SWOT分析
    Trustpower Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Alliancebernstein Holding Lp
    Alliancebernstein Holding Lp - Strategy, SWOT and Corporate Finance Report Summary Alliancebernstein Holding Lp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sundance Energy Australia Ltd (SEA):企業の財務・戦略的SWOT分析
    Summary Sundance Energy Australia Ltd (Sundance Energy Australia) is an onshore oil and gas exploration company that offers acquisition, exploration, production, operations, management, and development of crude oil and natural gas reserves. It develops projects in the Denver-Julesburg Basin located …
  • The Midcounties Co-operative:企業の戦略・SWOT・財務情報
    The Midcounties Co-operative - Strategy, SWOT and Corporate Finance Report Summary The Midcounties Co-operative - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • British Polythene Industries PLC:企業の戦略・SWOT・財務情報
    British Polythene Industries PLC - Strategy, SWOT and Corporate Finance Report Summary British Polythene Industries PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Allied International Corporation:企業の戦略・SWOT・財務情報
    Allied International Corporation - Strategy, SWOT and Corporate Finance Report Summary Allied International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • The Chugoku Electric Power Co., Inc.:企業の戦略・SWOT・財務分析
    The Chugoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary The Chugoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • PetroChina Co Ltd (857):企業の財務・戦略的SWOT分析
    PetroChina Co Ltd (857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • GE Lighting LLC:企業の戦略的SWOT分析
    GE Lighting LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Pharmathen Pharmaceuticals SA-製薬・医療分野:企業M&A・提携分析
    Summary Pharmathen Pharmaceuticals SA (Pharmathen) is a healthcare products provider that develops and markets generic products. The company’s products include oral antiplatelet agent, bactericidal cephalosporin antibiotic, retinoid, beta1-selective adrenergic receptor blocking agent, and others. It …
  • SolarEdge Technologies Inc (SEDG):企業の財務・戦略的SWOT分析
    SolarEdge Technologies Inc (SEDG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Allegra Orthopaedics Ltd (AMT)-医療機器分野:企業M&A・提携分析
    Summary Allegra Orthopaedics Ltd (Allegra), develops, manufactures and sells prosthetic implants and related orthopedic medical devices. Its major products include adult and adolescent clavicle fixation system and pin; shoulder implants; proximal humeral plates; trauma distal radial plates and syste …
  • Invenergy LLC:電力:M&Aディール及び事業提携情報
    Summary Invenergy LLC (Invenergy) is a full-service energy solutions provider. It invests, develops, constructs, owns, and operates renewable and other clean energy generation and storage facilities. The company captures, generates, and stores power from wind, solar, natural gas, and energy storage …
  • Neovasc Inc (NVC):企業の財務・戦略的SWOT分析
    Summary Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is design …
  • Rogers Corp (ROG):企業の財務・戦略的SWOT分析
    Summary Rogers Corp (Rogers) is a diversified company. The company offers advanced connectivity solutions, elastomeric solutions, power electronic solutions and performance materials. Its advanced connectivity solutions include laminates, bond ply or prepreg, copper clad laminates and conductive adh …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆